Clinical Trial Update: Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing postoperative adjuvant chemotherapy with versus without rh-endostatin in non-small cell lung cancer; current trial status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• rh-endostatin (recombinant human endostatin)

Snippet

Sponsor: Xinjiang Medical University | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN